These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate. Maina N; Maina KJ; Mäser P; Brun R Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860 [TBL] [Abstract][Full Text] [Related]
26. Chemotherapy for second-stage Human African trypanosomiasis. Lutje V; Seixas J; Kennedy A Cochrane Database Syst Rev; 2010 Aug; (8):CD006201. PubMed ID: 20687080 [TBL] [Abstract][Full Text] [Related]
27. Metronidazole and suramin combination in the treatment of arsenical refractory Rhodesian sleeping sickness--a case study. Foulkes JR Trans R Soc Trop Med Hyg; 1996; 90(4):422. PubMed ID: 8882195 [No Abstract] [Full Text] [Related]
28. Control of human African trypanosomiasis in the Quiçama focus, Angola. Ruiz JA; Simarro PP; Josenando T Bull World Health Organ; 2002; 80(9):738-45. PubMed ID: 12378293 [TBL] [Abstract][Full Text] [Related]
29. Endotoxins and the pathogenesis of Trypanosoma brucei brucei infection in mice. Alafiatayo RA; Crawley B; Oppenheim BA; Pentreath VW Parasitology; 1993 Jul; 107 ( Pt 1)():49-53. PubMed ID: 8355997 [TBL] [Abstract][Full Text] [Related]
30. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5). Tyler JW; Spears H; Nelson R J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577 [TBL] [Abstract][Full Text] [Related]
31. [Three patients with African sleeping sickness following a visit to Tanzania]. Mendonça Melo M; Rasica M; van Thiel PP; Richter C; Kager PA; Wismans PJ Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2552-6. PubMed ID: 12532670 [TBL] [Abstract][Full Text] [Related]
32. [Human African trypanosomiasis in Ivory Coast: biological characteristics after treatment. 812 cases treated in the Daloa focus (Ivory Coast)]. Miezan TW; Dje NN; Doua F; Boa F Bull Soc Pathol Exot; 2002 Dec; 95(5):362-5. PubMed ID: 12696377 [TBL] [Abstract][Full Text] [Related]
33. A woman with fever and rash after African safari. Uslan DZ; Jacobson KM; Kumar N; Berbari EF; Orenstein R Clin Infect Dis; 2006 Sep; 43(5):609, 661-2. PubMed ID: 16897839 [No Abstract] [Full Text] [Related]
35. [Diagnosis of sleeping sickness stage: towards a new approach]. Lejon V; Büscher P Bull Soc Pathol Exot; 2002 Dec; 95(5):338-40. PubMed ID: 12696371 [TBL] [Abstract][Full Text] [Related]
36. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness. Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469 [TBL] [Abstract][Full Text] [Related]
37. Endotoxin-polymyxin complexes in an improved enzyme-linked immunosorbent assay for IgG antibodies in blood donor sera to gram-negative endotoxin core glycolipids. Scott BB; Barclay GR Vox Sang; 1987; 52(4):272-80. PubMed ID: 2820153 [TBL] [Abstract][Full Text] [Related]
38. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study. Poltera AA; Hochmann A; Lambert PH Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886 [TBL] [Abstract][Full Text] [Related]
39. Drug resistance in human African trypanosomiasis. Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143 [TBL] [Abstract][Full Text] [Related]
40. Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: a review. Barclay GR Prog Clin Biol Res; 1995; 392():263-72. PubMed ID: 8524931 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]